Direct answer: Insurers usually want a prior-authorization form, chart notes, diagnosis details, BMI data, and a clear reason the medication is medically appropriate
Those with a history of pancreatitis, significant thyroid issues, or severe gastrointestinal problems should avoid tirzepatide
With advancing age, carnitine levels decline in all our tissues
By merging clinical expertise with digital convenience, we help you take control of your metabolic health without the stress of traditional office visits
Glucagon is also thought to increase energy expenditure, possibly via increased brown adipose tissue activity (Baggio and Drucker, 2021)
Head-to-Head Trial Shows Eli Lilly's Oral GLP-1 Orforglipron Outperforms Oral Semaglutide (ACHIEVE-3, The Lancet)